|
1
|
Zhang J, Lazarenko OP, Blackburn ML,
Shankar K, Badger TM, Ronis MJ and Chen JR: Feeding blueberry diets
in early life prevent senescence of osteoblasts and bone loss in
ovariectomized adult female rats. PLoS One. 6:e244862011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao X, Wu ZX, Zhang Y, Gao MX, Yan YB,
Cao PC, Zang Y and Lei W: Locally administered perindopril improves
healing in an ovariectomized rat tibial osteotomy model. PLoS One.
7:e332282012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cano A, Chedraui P, Goulis DG, Lopes P,
Mishra G, Mueck A, Senturk LM, Simoncini T, Stevenson JC, Stute P,
et al: Calcium in the prevention of postmenopausal osteoporosis:
EMAS clinical guide. Maturitas. 107:7–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kikuta J and Ishii M: Bone imaging:
Osteoclast and osteoblast dynamics. Methods Mol Biol. 1763:1–9.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu-Lee LY, Yu G, Lee YC, Lin SC, Pan J,
Pan T, Yu KJ, Liu B, Creighton CJ, Rodriguez-Canales J, et al:
Osteoblast-secreted factors mediate dormancy of metastatic prostate
cancer in the bone via activation of the
TGFβRIII-p38MAPK-pS249/T252RB pathway. Cancer Res. 78:2911–2924.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matsuo K: Cross-talk among bone cells.
Curr Opin Nephrol Hypertens. 18:292–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee WC, Guntur AR, Long F and Rosen CJ:
Energy metabolism of the osteoblast: Implications for osteoporosis.
Endocr Rev. 38:255–266. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Black DM and Rosen CJ: Clinical practice.
Postmenopausal osteoporosis. N Engl J Med. 374:254–262. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheung WH, Miclau T, Chow SK, Yang FF and
Alt V: Fracture healing in osteoporotic bone. Injury. 47 (Suppl
2):S21–S26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sanchez C, Mazzucchelli G, Lambert C,
Comblain F, DePauw E and Henrotin Y: Comparison of secretome from
osteoblasts derived from sclerotic versus non-sclerotic subchondral
bone in OA: A pilot study. PLoS One. 13:e01945912018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hara Y, Ghazizadeh M, Shimizu H, Matsumoto
H, Saito N, Yagi T, Mashiko K, Mashiko K, Kawai M and Yokota H:
Delayed expression of circulating TGF-β1 and BMP-2 levels in human
nonunion long bone fracture healing. J Nippon Med Sch. 84:12–18.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Folwarczna J, Zych M and Trzeciak HI:
Effects of curcumin on the skeletal system in rats. Pharmacol Rep.
62:900–909. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Uemura H, Yasui T, Miyatani Y, Yamada M,
Hiyoshi M, Arisawa K and Irahara M: Circulating profiles of
osteoprotegerin and soluble receptor activator of nuclear factor
kappaB ligand in post-menopausal women. J Endocrinol Invest.
31:163–168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ibáñez L, Ferrándiz ML, Brines R, Guede D,
Cuadrado A and Alcaraz MJ: Effects of Nrf2 deficiency on bone
microarchitecture in an experimental model of osteoporosis. Oxid
Med Cell Longev. 2014:7265902014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park CK, Lee Y, Kim KH, Lee ZH, Joo M and
Kim HH: Nrf2 is a novel regulator of bone acquisition. Bone.
63:36–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu H, Zhang L, Itoh K, Yamamoto M, Ross
D, Trush MA, Zweier JL and Li Y: Nrf2 controls bone marrow stromal
cell susceptibility to oxidative and electrophilic stress. Free
Radic Biol Med. 41:132–143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maicas N, Ferrándiz ML, Brines R, Ibáñez
L, Cuadrado A, Koenders MI, van den Berg WB and Alcaraz MJ:
Deficiency of Nrf2 accelerates the effector phase of arthritis and
aggravates joint disease. Antioxid Redox Signal. 15:889–901. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aw Yeang HX, Hamdam JM, Al-Huseini LM,
Sethu S, Djouhri L, Walsh J, Kitteringham N, Park BK, Goldring CE
and Sathish JG: Loss of transcription factor nuclear
factor-erythroid 2 (NF-E2) p45-related factor-2 (Nrf2) leads to
dysregulation of immune functions, redox homeostasis, and
intracellular signaling in dendritic cells. J Biol Chem.
287:10556–10564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee P, Linderman JD, Smith S, Brychta RJ,
Wang J, Idelson C, Perron RM, Werner CD, Phan GQ, Kammula US, et
al: Irisin and FGF21 are cold-induced endocrine activators of brown
fat function in humans. Cell Metab. 19:302–309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee MJ, Lee SA, Nam BY, Park S, Lee SH,
Ryu HJ, Kwon YE, Kim YL, Park KS, Oh HJ, et al: Irisin, a novel
myokine is an independent predictor for sarcopenia and carotid
atherosclerosis in dialysis patients. Atherosclerosis. 242:476–482.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Palermo A, Strollo R, Maddaloni E,
Tuccinardi D, D'Onofrio L, Briganti SI, Defeudis G, De Pascalis M,
Lazzaro MC, Colleluori G, et al: Irisin is associated with
osteoporotic fractures independently of bone mineral density, body
composition or daily physical activity. Clin Endocrinol (Oxf).
82:615–619. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Velders M and Diel P: How sex hormones
promote skeletal muscle regeneration. Sports Med. 43:1089–1100.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bednarek-Tupikowska G, Tupikowski K,
Bidzińska B, Bohdanowicz-Pawlak A, Antonowicz-Juchniewicz J,
Kosowska B and Milewicz A: Serum lipid peroxides and total
antioxidant status in postmenopausal women on hormone replacement
therapy. Gynecol Endocrinol. 19:57–63. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tu KN, Lie JD, Wan CKV, Cameron M, Austel
AG, Nguyen JK, Van K and Hyun D: Osteoporosis: A review of
treatment options. PT. 43:92–104. 2018.
|
|
25
|
Zhang L, Yin X, Wang J, Xu D, Wang Y, Yang
J, Tao Y, Zhang S, Feng X and Yan C: Associations between VDR gene
polymorphisms and osteoporosis risk and bone mineral density in
postmenopausal women: A systematic review and meta-analysis. Sci
Rep. 8:981–989. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saei-Dehkordi SS, Tajik H, Moradi M and
Khalighi-Sigaroodi F: Chemical composition of essential oils in
Zataria multiflora Boiss. from different parts of Iran and
their radical scavenging and antimicrobial activity. Food Chem
Toxicol. 48:1562–1567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K,
Sonoyama W, Patel V, Gutkind S, Young M, Gronthos S, et al:
Pharmacologic stem cell based intervention as a new approach to
osteoporosis treatment in rodents. PLoS One. 3:e26152008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang C, Zeng YP and Yang T: Irisin in
restraining IL-1, IL-6, TNF-α and M-CSF expression and its effect
in preventing post-menopause osteoporosis. China Pharmaceuticals.
24:15–17. 2015.
|
|
29
|
Klionsky DJ: Autophagy: From phenomenology
to molecular understanding in less than a decade. Nat Rev Mol Cell
Biol. 8:931–937. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thirunavukkarasu K, Halladay DL, Miles RR,
Yang X, Galvin RJ, Chandrasekhar S, Martin TJ and Onyia JE: The
osteoblast-specific transcription factor Cbfa1 contributes to the
expression of osteoprotegerin, a potent inhibitor of osteoclast
differentiation and function. J Biol Chem. 275:25163–25172. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu H, Wu F, Zhang H, Yang C, Li K, Wang H,
Yang H, Liu Y, Ding B, Tan Y, et al: Actin cytoskeleton mediates
BMP2-Smad signaling via calponin 1 in preosteoblast under simulated
microgravity. Biochimie. 138:184–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kanzaki H, Shinohara F, Kajiya M and
Kodama T: The Keap1/Nrf2 protein axis plays a role in osteoclast
differentiation by regulating intracellular reactive oxygen species
signaling. J Biol Chem. 288:23009–23020. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pellegrini GG, Morales CC, Wallace TC,
Plotkin LI and Bellido T: Avenanthramides prevent osteoblast and
osteocyte apoptosis and induce osteoclast apoptosis in vitro in an
Nrf2-independent manner. Nutrients. 8:423–436. 2016. View Article : Google Scholar
|
|
34
|
Ibáñez L, Ferrándiz ML, Brines R, Guede D,
Cuadrado A and Alcaraz MJ: Effects of Nrf2 deficiency on bone
microarchitecture in an experimental model of osteoporosis. Oxid
Med Cell Longev. 2014:7265902014. View Article : Google Scholar : PubMed/NCBI
|
